Skip to content

Clinical trials

Leukemia, Myeloid, Acute trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Country / region: India Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20111
20121
20131
20151
20161
20211
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting2
Completed2
Unknown status2
Recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie1
All India Institute of Medical Sciences1
Aurigene Discovery Technologies Limited1
Boehringer Ingelheim1
Dr Atul Sharma1
ECOG-ACRIN Cancer Research Group1
Eisai Inc.1
Novartis Pharmaceuticals1
Sellas Life Sciences Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute9
Bronchiolitis Obliterans Syndrome1
Congenital Abnormalities1
Graft vs Host Disease1
Leukemia, Erythroblastic, Acute1
Leukemia, Megakaryoblastic, Acute1
Leukemia, Monocytic, Acute1
Leukemia, Myelomonocytic, Acute1
Lymphoma, Non-Hodgkin1
Myelodysplastic Syndromes1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.